Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9298973rdf:typepubmed:Citationlld:pubmed
pubmed-article:9298973lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:9298973lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:9298973lifeskim:mentionsumls-concept:C0032611lld:lifeskim
pubmed-article:9298973lifeskim:mentionsumls-concept:C1419917lld:lifeskim
pubmed-article:9298973lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:9298973lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:9298973lifeskim:mentionsumls-concept:C0300511lld:lifeskim
pubmed-article:9298973lifeskim:mentionsumls-concept:C0666222lld:lifeskim
pubmed-article:9298973pubmed:issue38lld:pubmed
pubmed-article:9298973pubmed:dateCreated1997-10-16lld:pubmed
pubmed-article:9298973pubmed:abstractTextThe solution conformation of a peptide LYS(11-36), which corresponds to the beta-sheet region in T4 lysozyme, has been examined in aqueous solution, TFE, and SDS micelles by CD and 1H NMR spectroscopy. Secondary structure predictions suggest some beta-sheet and turn character in aqueous solution but predict a helical conformation in a more hydrophobic environment. The predictions were supported by the CD and NMR studies which showed the peptide to be relatively unstructured in aqueous solution, although there was some evidence of a beta-turn conformer which was maintained in 200 mM SDS and, to a lesser extent, in 50% TFE. The peptide was significantly helical in the presence of either 50% TFE or 200 mM SDS. TFE and SDS titrations showed that the peptide could form helical, sheet, or extended structure depending on the TFE or SDS concentration. The studies indicate that peptide environment is the determining factor in secondary structure adopted by LYS(11-36).lld:pubmed
pubmed-article:9298973pubmed:languageenglld:pubmed
pubmed-article:9298973pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9298973pubmed:citationSubsetIMlld:pubmed
pubmed-article:9298973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9298973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9298973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9298973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9298973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9298973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9298973pubmed:statusMEDLINElld:pubmed
pubmed-article:9298973pubmed:monthSeplld:pubmed
pubmed-article:9298973pubmed:issn0006-2960lld:pubmed
pubmed-article:9298973pubmed:authorpubmed-author:WebbG DGDlld:pubmed
pubmed-article:9298973pubmed:authorpubmed-author:SalvatoreDDlld:pubmed
pubmed-article:9298973pubmed:authorpubmed-author:CraigD FDFlld:pubmed
pubmed-article:9298973pubmed:authorpubmed-author:McLeishM JMJlld:pubmed
pubmed-article:9298973pubmed:authorpubmed-author:NajbarL VLVlld:pubmed
pubmed-article:9298973pubmed:issnTypePrintlld:pubmed
pubmed-article:9298973pubmed:day23lld:pubmed
pubmed-article:9298973pubmed:volume36lld:pubmed
pubmed-article:9298973pubmed:ownerNLMlld:pubmed
pubmed-article:9298973pubmed:authorsCompleteYlld:pubmed
pubmed-article:9298973pubmed:pagination11525-33lld:pubmed
pubmed-article:9298973pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:meshHeadingpubmed-meshheading:9298973-...lld:pubmed
pubmed-article:9298973pubmed:year1997lld:pubmed
pubmed-article:9298973pubmed:articleTitleConformational analysis of LYS(11-36), a peptide derived from the beta-sheet region of T4 lysozyme, in TFE and SDS.lld:pubmed
pubmed-article:9298973pubmed:affiliationVictorian College of Pharmacy, Monash University, 381 Royal Pde, Parkville 3052, Australia.lld:pubmed
pubmed-article:9298973pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9298973pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9298973pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9298973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9298973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9298973lld:pubmed